Navigation Links
EpiCept Provides Update on Clinical and Regulatory Progress with Ceplene(TM) and EpiCept(TM) NP-1 Cream
Date:1/22/2008

TARRYTOWN, N.Y., Jan. 22 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today provided updates on the regulatory and clinical status of Ceplene(TM) (histamine dihydrochloride) and EpiCept(TM) NP-1 Cream.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

EpiCept announced today that its Marketing Authorization Application (MAA) seeking marketing approval for Ceplene in the European Union has advanced to the next important step. The Company has submitted full written responses to the Day 180 List of Outstanding Issues to the Committee for Human Medicinal Products (CHMP). With this response, EpiCept believes it has now addressed all outstanding issues related to the MAA.

The next regulatory milestone for Ceplene will be an Oral Explanation (OE) before all member states of the CHMP reviewing this MAA. The OE will be scheduled for later this quarter. Following this hearing, a recommendation on the approvability of Ceplene will be issued by the CHMP, which will be followed by a final decision by the European Commission.

EpiCept also said today that it expects to unblind and announce the results from its Phase II "Neuracept" trial for EpiCept NP-1 cream in patients suffering from diabetic peripheral neuropathy (DPN) in the near future. This study was designed to collect data on 200 patients; because 231 patients were randomized in this trial, slightly more time than was previously anticipated is required to compile and analyze the data.

About Ceplene

Ceplene is EpiCept's registration-stage compound for the treatment of AML. Ceplene is designed to protect lymphocytes responsible for immune-mediated destruction of residual leukemic cells. Laboratory research has demonstrated that Ceplene reduces formation of oxygen radicals from phagocytes, inhibiting NADPH oxidase and protecting IL-2-activat
'/>"/>

SOURCE EpiCept Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407
2. EpiCept Reports Regulatory Progress on Ceplene(TM)
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. DuPont Provides Technology for Washington Hospital Centers Emergency Department
5. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
6. ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
7. Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
8. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
9. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
10. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
11. Replidyne Provides Strategic Update

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., IRVINE,Calif.,Nov.23/PRNewswire/--AdvancedSte...ventionsolutionprovider,announcedtodaytheacquisiti...,aprivatelyhelddeveloperofinnovativedisinfectionpr...infections.Termsoftheacquisitionwerenotdisclosed. ...eadecontaminationtechnologythatprovidesdisinfectio...
(Date:11/20/2009)... , BOSTON, Nov. 20 The Uni... upheld an earlier District Court ruling yesterday...ge Wholesale Price (AWP) pharmaceutical litigation... (Logo: http://www.newscom.com/cgi-bin/prnh/20080...ment that awarded consumers who purchased the phar...
(Date:11/20/2009)... , LOUISVILLE, Ky., Nov. 20 /PRNewswire/ -...tigators (NADDI) today announced a new initiative ...rsor Log Exchange (NPLEx) is a multi-state electro...tions on over-the-counter (OTC) medicines containi...le. The technology for NPLEx is based on a system...
Breaking Medicine Technology:ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 1KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 2KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 3KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 4Scientists remove amyloid plaques from brains of live animals with Alzheimers disease 10367 1Scientists remove amyloid plaques from brains of live animals with Alzheimers disease 10367 2SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 1SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 2SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 3SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 4
...esented on Valopicitabine Combined,with an Investi...il 12, 2007 /PRNewswire-FirstCall/ --,Idenix Pharm...phase,IIb studies of the novel combination of valo...a (Pegasys(R)) in both treatment-naive,and treatme...e-1,strain of the hepatitis C virus (HCV). These d...
...osts of eradicating,poliomyelitis from the remaini...m, are much lower than the long term costs of tryi...a recently developed,monovalent vaccine is almost ...litis than an existing trivalent vaccine. These ar...d in an upcoming,issue of The Lancet. , Both Artic...
Other Medicine Technology:Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 4Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 5Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 6Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 7Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3
(Date:11/23/2009)... ,, NEWORLEANS,Nov.23/PRNewswire/--Thanksgiv...#174;.Stronginitstradition,theClassicrepresentsthe...thanagameforthecityofNewOrleansandthoseinattendanc...GCWasche,thisisachanceforsomedowntimebeforetheywor..., Aftertwoyearsofconstruction,PettyOfficerClaud...
(Date:11/23/2009)... , Animal studies suggest that adding flaxseed oi...s in post-menopausal women and women with diabetes...ternational Journal of Food Safety, Nutrition and ...e National Research Center, in Cairo, Egypt, have ...evaluated how flaxseed oil in the diet might delay...
(Date:11/23/2009)... , Since 1996, crop plants genetically modified t...tain insects, yet safe for people, have been plant...e popularity of these Bt crops, named after the ba... ability to kill some major pests, allowing farmer...y reducing insecticide sprays. , However, since ...
(Date:11/23/2009)... Adding drug to chemo regimen may improve patient... Nov. 23 (HealthDay News) -- A new combination dru...advanced biliary-tract cancers, researchers say. ,...tal Cancer Center in Boston found that survival an...mab (Avastin), an angiogenesis inhibitor that has ...
(Date:11/23/2009)... HIV patients who have it take longer to get sick...hDay News) -- Scientists report that a genetic var...ease progression in HIV-infected patients. , ...ears longer to develop AIDS and die of complicatio...ors that vary across individuals that make a perso...
Breaking Medicine News(10 mins):Health News:Nothing Is Like Being There 2Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2Health News:Genetic Variant Slows AIDS Progression 2
...s that getting hospitals conscious about quality o...ts dying in that hospital. 26 percent fewer p...ttack when hospitals used quality-improvement // ...steps included a checklist that doctors, nurses an...
...boratories Thursday announced it had entered a co-...enmark-based Rheoscience A/S for the joint develop...the pact, Rheoscience will fund all costs associat... will pay Rheoscience a pre-determined amount towa...
... and team from the Institute of Tropical Medicine ...al AIDS, in which they have said that the HIV viru...iplication rate and is now more sensitive to anti-...ollected during 2002-03. The researchers compared ...
...on form of thalassaemia disease may not require bl...oglobin E ? thalassaemia—the commonest form of sev...managed without transfusion in many patients, sugg...es of donated blood—a scarce resource in many coun...
...ein has helped bald mice to get fur on the body, s... Catherine C. Thompson and colleagues at Johns...nd studied a gene known as Hairless, which encodes...rmal. But once hair is shed, it does not grow back...
...ss is considering whether to temporarily ban the E...man tests to determine whether a pesticide should ... decide whether to place a one year moratorium on ...es approved by the agency for marketing. The...
Other Medicine News:Health News:Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru 2Health News:US Senate Votes against Testing of Pesticide on Humans 2
FF 450plus IR
... for fast and easy operation with advanced lens me...utomatically held when the lens is properly aligne...The sophisticated alignment system guides you to c...designed with a small footprint, occupying little ...
CR6-45NM Non-Mydriatic Retinal Camera
TRC-50FXC
Medicine Products: